Sonavex Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $3.1M

  • Investors
  • 28

Sonavex General Information

Description

Developer of a bioresorbable and echogenic equipment technology designed to mark at-risk blood vessels. The company's technology collects arteriovenous fistula volumetric flow rate, diameter, and depth information at the dialysis clinic to support maturation assessment, such that the site can be easily assessed for future complications, enabling healthcare providers to determine blood flow and morphology of vessels and get actionable data to deliver patient care.

Contact Information

Website
www.sonavex.com
Formerly Known As
Veridian Surgical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2835 O'Donnell Street
  • Suite 200
  • Baltimore, MD 21224
  • United States
+1 (443)
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Automation/Workflow Software
Outcome Management (Healthcare)
Corporate Office
  • 2835 O'Donnell Street
  • Suite 200
  • Baltimore, MD 21224
  • United States
+1 (443)

Sonavex Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sonavex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Later Stage VC (Series B) 13-Jul-2026 $3.1M Completed Clinical Trials - Phase 4
19. Later Stage VC (Series A2) 25-Oct-2024 Completed Clinical Trials - Phase 4
18. Grant 25-Sep-2024 Completed Clinical Trials - Phase 4
17. Secondary Transaction - Private Completed Clinical Trials - Phase 4
16. Grant 30-Jun-2022 Completed Clinical Trials - Phase 4
15. Grant 25-May-2022 Completed Clinical Trials - Phase 4
14. Grant 15-Sep-2021 Completed Clinical Trials - Phase 4
13. Accelerator/Incubator 01-Jun-2020 Completed Clinical Trials - Phase 4
12. Debt - PPP 15-Apr-2020 $193K $9.1M Completed Clinical Trials - Phase 4
11. Later Stage VC (Series A1) 31-Jan-2020 $4.3M $9.1M Completed Clinical Trials - Phase 4
To view Sonavex’s complete valuation and funding history, request access »

Sonavex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A2
Series A 637,816 $0.000100 $7.04 $7.04 1x $7.04 18.81%
Seed 140,464 $0.000100 $2.37 $2.37 1x $2.37 4.14%
To view Sonavex’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sonavex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bioresorbable and echogenic equipment technology designed to mark at-risk blood vessels. The company's te
Diagnostic Equipment
Baltimore, MD
25 As of 2026

Broomfield, CO
 

Redmond, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sonavex Competitors (7)

One of Sonavex’s 7 competitors is Alio, a Venture Capital-Backed company based in Broomfield, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alio Venture Capital-Backed Broomfield, CO
EchoNous Private Equity-Backed Redmond, WA
HistoSonics Private Equity-Backed Plymouth, MN
Synaptive Medical Formerly VC-backed Mississauga, Canada
Monteris Medical Venture Capital-Backed Minnetonka, MN
You’re viewing 5 of 7 competitors. Get the full list »

Sonavex Patents

Sonavex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250073398-A1 Ultrasound blood vessel imaging and cannulation assistance systems Pending 05-Sep-2023
US-20260263033-A1 Ultrasound blood vessel imaging and cannulation assistance systems Pending 05-Sep-2023
WO-2026054807-A1 Ultrasound blood vessel imaging and cannulation assistance systems Pending 05-Sep-2023
AU-2016293866-A1 Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity Inactive 16-Jul-2015
CA-2985498-A1 Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity Inactive 16-Jul-2015 B29C44/02
To view Sonavex’s complete patent history, request access »

Sonavex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sonavex Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accelerator Venture Partners Venture Capital Minority
Biohealth Innovation Corporation Minority
GenHenn Capital Family Office Minority
JSTAR Capital Venture Capital Minority
Keiretsu Forum Angel Group Minority
You’re viewing 5 of 28 investors. Get the full list »

Sonavex FAQs

  • When was Sonavex founded?

    Sonavex was founded in 2013.

  • Where is Sonavex headquartered?

    Sonavex is headquartered in Baltimore, MD.

  • What is the size of Sonavex?

    Sonavex has 25 total employees.

  • What industry is Sonavex in?

    Sonavex’s primary industry is Diagnostic Equipment.

  • Is Sonavex a private or public company?

    Sonavex is a Private company.

  • What is the current valuation of Sonavex?

    The current valuation of Sonavex is .

  • What is Sonavex’s current revenue?

    The current revenue for Sonavex is .

  • How much funding has Sonavex raised over time?

    Sonavex has raised $27.2M.

  • Who are Sonavex’s investors?

    Accelerator Venture Partners, Biohealth Innovation, GenHenn Capital, JSTAR Capital, and Keiretsu Forum are 5 of 28 investors who have invested in Sonavex.

  • Who are Sonavex’s competitors?

    Alio, EchoNous, HistoSonics, Synaptive Medical, and Monteris Medical are some of the 7 competitors of Sonavex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process